Varicella Zoster Virus Infection Clinical Trial
Official title:
An Open-label, Bridging Study to Assess the Safety and Immunogenicity of BARYCELA Inj. (Live Attenuated Varicella Vaccine for Injection) in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
The goal of this bridging study is to assess the safety and immunogenicity of BARYCELA inj. in healthy Vietnamese children aged between 12 months to 12 years. The main questions it aims to answer are: - Safety of BARYCELA inj. (Live attenuated varicella vaccine for injection) - Immunogenicity of BARYCELA inj. (Live attenuated varicella vaccine for injection) Participants will be administered subcutaneously with a single dose(0.5 mL dose) of the BARYCELA inj.(MG1111) on the upper arm (brachia lateral).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01682109 -
Palatability Testing of a New Paediatric Formulation of Valacyclovir
|
Phase 4 | |
Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
Not yet recruiting |
NCT06409494 -
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
|
Phase 1 | |
Recruiting |
NCT05604911 -
Herpes Virus Infections in Kidney Transplant Patients
|
||
Recruiting |
NCT05532540 -
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
|
||
Completed |
NCT01689285 -
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
|
Phase 1 | |
Terminated |
NCT04081480 -
Pharmacokinetics of Valacyclovir Oral Solution in Children
|
N/A | |
Recruiting |
NCT04403139 -
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
|
Phase 4 |